Regulacje i polityka gospodarcza · 18/11/1997
NIH Grants Exclusive License for Immunodampening Technology to Biological Memetics, Inc.
The National Institutes of Health (NIH) is granting an exclusive worldwide license to Biological Memetics, Inc. to practice a patent for immunodampening technology, with the goal of developing vaccines for infectious diseases in animals and humans.